(Q44229401)

1 December 2017

title

Eosinophils and eosinophilic cationic protein in induced sputum and blood: effects of budesonide and terbutaline treatment (English)

1 reference

1 December 2017

0 references

1 reference

2

Robert J Hancox

1 reference

1 December 2017

4

Chris M Frampton

1 reference

1 December 2017

5

G Ian Town

1 reference

1 December 2017

6

D Robin Taylor

1 reference

1 December 2017

Ruth E Aldridge

1

1 reference

1 December 2017

Jan O Cowant

series ordinal

3

1 reference

1 December 2017

publication date

1 November 2002

1 reference

Annals of Allergy, Asthma & Immunology

1 December 2017

published in

1 reference

1 December 2017

volume

89

1 reference

1 December 2017

issue

5

1 reference

1 December 2017

page(s)

492-497

1 reference

Serum measurement of eosinophil cationic protein in the management of asthma

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962087-X

7 January 2021

Use of induced sputum cell counts to investigate airway inflammation in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962087-X

7 January 2021

Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962087-X

7 January 2021

Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962087-X

7 January 2021

Monitoring of asthma inflammation by serum measurements of eosinophil cationic protein (ECP). A new clinical approach to asthma management

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962087-X

7 January 2021

Measuring airway inflammation in asthma: Eosinophils and eosinophilic cationic protein in induced sputum compared with peripheral blood

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962087-X

7 January 2021

Eosinophil cationic protein levels in induced sputum correlate with the severity of bronchial asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962087-X

7 January 2021

Eosinophilic inflammation assessed by induced sputum in corticosteroid-dependent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962087-X

7 January 2021

Sputum in severe exacerbations of asthma: kinetics of inflammatory indices after prednisone treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962087-X

7 January 2021

Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. The effects of antiasthmatic treatment with budesonide or terbutaline

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962087-X

7 January 2021

Effect of low-dose beclomethasone dipropionate on asthma control and airway inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962087-X

7 January 2021

Eosinophil cationic protein (ECP) and eosinophil protein X (EPX) concentrations in serum and bronchial lavage fluid in asthma. Effect of prednisolone treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962087-X

7 January 2021

An inhaled steroid improves markers of airway inflammation in patients with mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962087-X

7 January 2021

Effects of terbutaline and budesonide on sputum cells and bronchial hyperresponsiveness in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962087-X

7 January 2021

Non-invasive assessment of bronchial inflammation in asthma: no correlation between eosinophilia of induced sputum and bronchial responsiveness to inhaled hypertonic saline

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962087-X

7 January 2021

Analysis of induced sputum to examine the effects of prednisone on airway inflammation in asthmatic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962087-X

7 January 2021

Comparison between eosinophilic markers in induced sputum and blood in asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962087-X

7 January 2021

Do sputum eosinophils and ECP relate to the severity of asthma?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962087-X

7 January 2021

Serum eosinophil cationic protein in relation to bronchial asthma in a young Swedish population

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962087-X

7 January 2021

Clinical value of monitoring eosinophil activity in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962087-X

7 January 2021

The use of serum eosinophil cationic protein (ECP) in the management of steroid therapy in chronic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962087-X

7 January 2021

Serum eosinophilic cationic protein and blood eosinophil counts for the prediction of the presence of airways inflammation in children with wheezing

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962087-X

7 January 2021

10.1016/S1081-1206(10)62087-X

Identifiers

DOI

1 reference

1 December 2017

1 reference